The 4th Annual Cancer Research & Oncology Virtual Conference is now On Demand! This premier cancer research conference makes it easier and more cost-effective for the cancer research community to come together online to learn about recent advances in cancer research. The conference has proven to be a great success in disseminating knowledge and encouraging collaboration and connections between colleagues. View this conference at no charge, at any time!
Cancer Research & Oncology 2016 features informative presentations from keynote speakers and experts including; Dr. Giacinto Scoles, Dr. Gordon Freeman, Dr. Louise Perkins, Dr. David Albala, Dr. Judd Moul, And Dr. Raoul Concepcion. Check out the virtual conference to view these and other great speakers at your convenience.
Watch this video to learn about this exciting conference!
Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global cancer community with a high degree of interaction through live-streaming video and chat sessions.
Topics for this year’s conference include:
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.
Use #LRcancer to follow the conversation
For information on becoming a sponsor or exhibitor, please click here.
Fluidigm creates and manufactures innovative technologies and life-science tools designed to revolutionize biology through a relentless pursuit of scientific truth. Its core technologies are based on microfluidics and mass cytometry, and enable the exploration and analysis of ...See more See less
Agilent (www.agilent.com) is a leader in life sciences, clinical research, diagnostics and applied chemical markets. With over 11,000 employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling ...See more See less
Personalis is a genomic sequencing services provider with a patented ACE (Accuracy & Content Enhanced) technology that augments coverage in difficult-to-sequence regions of the genome, such as areas of high-GC content. The ACE Platform yields the most accurate and comprehensive ...See more See less
At Intermountain Precision Genomics we use a revolutionary method of gene sequencing. Our experts now deliver more precise medicine than ever before and are on the forefront of personalized cancer testing for all types of genetic mutations. Our process is unique because we offer ...See more See less
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications ...See more See less
Oxford Nanopore Technologies™ is developing a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins. The MinION™ device, the PromethION™ and GridION™ systems are designed to provide novel qualities in ...See more See less
QIAGEN N.V., a Netherlands holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular information. Sample technologies are used to isolate and process DNA, RNA and proteins from biological ...See more See less
Bio-Rad Laboratories (NYSE: BIO and BIOb) continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets. Founded in 1952, Bio-Rad has a global ...See more See less
Dharmacon (part of GE Healthcare) continues to be the industry leader in the field of RNA chemistry, RNAi biology and high-throughput screening, and partners with the RNAi screening community through participation in the RNAi Global Initiative. With Dharmacon, you get access to ...See more See less
Envigo provides essential products and research services for biopharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. Our company is founded on the principle that research partnerships depend on unmatched ...See more See less
Our goal is simply to help researchers gain a better understanding of proteins and their role in disease. We develop and commercialize proprietary systems and consumables for protein analysis that ultimately help reveal new insights into the true nature of proteins. Our goal is ...See more See less
Headquartered in Pleasanton, California, Roche Molecular Diagnostics (RMD) is a business area of Roche Diagnostics (Basel, Switzerland) that develops, manufactures and supplies a wide array of innovative medical diagnostic products, services, tests, platforms and technologies ...See more See less
At Illumina, we apply innovative technologies for studying genetic variation and function, making studies possible that were not even imaginable just a few years ago. These revolutionary tools for DNA and RNA analysis are enabling rapid advances in disease research, drug ...See more See less
ImmunoChemistry Technologies, LLC provides quality laboratory services and research reagents. As a contract service laboratory, ICT specializes in custom immunoassay development, manufacturing, conjugation, lyophilization, and consulting services. ICT is focused on ELISA ...See more See less
LI-COR Biosciences offers imaging systems, analysis software, and IRDye® infrared dye reagents for quantitative protein and small animal imaging. LI-COR provides the complete solution for Western blots with its Odyssey® Infrared Imaging Systems, C-DiGit® Blot Scanner, analysis ...See more See less
Miltenyi Biotec's mission is to improve scientific understanding and medical progress. We provide products and services that advance biomedical research and cellular therapy. Honoring this mission drives our commitment to support the translation of basic research into therapy in ...See more See less
MBL International Corporation is a leading life science company focused on providing high-quality products and solutions for life science research and clinical diagnostics. Established in 1993 as a subsidiary of Medical and Biological Laboratories Co. Ltd, Nagoya, Japan, MBL ...See more See less
We are here for the people we serve in their pursuit of healthy lives. This has been the way of Abbott for more than a century-passionately and thoughtfully translating science into lasting contributions to health. Our products encircle life, from newborns to aging adults, from ...See more See less
Advaita develops comprehensive bioinformatics tools that bridge the gap between the ability to gather and interpret genomic variants, transcriptomics, and proteomics data. Our advanced methods and platform provide researchers with the most advanced and secure tools to understand ...See more See less
ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the ...See more See less
Boster is an antibody manufacturer founded in 1993 by famed histologist, Steven Xia. Over the past two decades, Boster's products have been cited in over 12,000 publications. We specialize in developing ELISA kits and antibodies with high affinity and at affordable prices. One ...See more See less
Cofactor is a next-generation genomics company. Working with the largest life-science and pharmaceutical companies in the world, we've developed cutting-edge, streamlined, and scalable protocols to interrogate RNA. Whether you require delivery of FASTQ files or full ...See more See less
Desktop Genetics walks you through every aspect of your CRISPR experiment from design to data. CRISPR has a wide range of utility; it can be used to test the essentiality of unknown coding regions or to search for a drug target for a disease therapeutic. Alternatively, CRISPR is ...See more See less
The IncuCyte® Real-Time Quantitative Live-Cell Analysis System, designed by Essen BioScience, Inc. is the first system to enable quantification of cell behavior over time (from hours to weeks) by automatically gathering and analyzing images around the clock. The IncuCyte® ...See more See less
Horizon Discovery (Horizon) is a revenue-generating international life science company that supplies products, services and research programmes to over 1,000 customers in 50 countries. Our offering is increasingly powering the research of academic, biotech, diagnostic ...See more See less
Innova Biosciences are world leading experts in easy-to-use, cutting-edge bioconjugation technologies and services. The Company has the flexibility to support scientists from academia through to commercial manufacturing, developing and supplying reagent products to make science ...See more See less
Kerafast is a reagent company whose primary mission is to make unique laboratory-made research tools easily accessible to the global scientific community. Our portfolio includes cell lines, antibodies, small molecules, dyes and more. Since our founding in 2011, researchers from ...See more See less
As an innovator in reagents and tools, our purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, we offer highly validated biological binders and assays to address ...See more See less
Lumigen, a Beckman Coulter company, is one of the world's largest suppliers of chemiluminescent reagents to the clinical immunodiagnostics market. Lumigen is continually at the forefront of the development of innovative new detection technologies for the clinical laboratory and ...See more See less
labfolder is an innovative software company that has developed an revolutionary platform, connecting everything essential for scientific research. The Electronic Lab Notebook (ELN) and a Laboratory Information Management System (LIMS) come together as one. The platform can be ...See more See less
MédiMabs' mission is to be the "Go To" supplier, sought by biomedical researchers seeking quality antibodies and services that are required for the rapidly evolving, complex applications of their projects, generated in a profitable, regulated laboratory and supported by ...See more See less
Oasis Diagnostics® specializes in two areas of the in vitro diagnostics business- salivary diagnostics and genomics / transcriptomics. Technologies include unique devices for standardized collection of saliva for applications in [non-invasive] liquid biopsy testing ...See more See less
aylor & Francis partners with world-class authors, from leading scientists and researchers, to scholars and professionals operating at the top of their fields. Together, we publish in all areas of the Humanities, Social Sciences, Behavioural Sciences, Science, Technology and ...See more See less
Vigene Biosciences is a leader in viral vector based gene delivery for both life science research, gene therapy and cell therapy purposes. Headquartered in Rockville, Maryland, Vigene offers AAV, lentivirus and adenovirus based products and custom services. Both research grade ...See more See less
What is the CHTN? The Cancer Diagnosis Program of the National Cancer Institute (NCI) initiated the Cooperative Human Tissue Network (CHTN) in 1987 to provide increased access to human tissue for basic and applied scientists from academia and industry to accelerate the ...See more See less
Founded in 2004, Research Square provides innovative solutions to help researchers successfully communicate their work. These solutions include author and manuscript services from AJE American Journal Experts as well publisher solutions such as peer review, independent ...See more See less
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities.
AllSeq has created the world's first Sequencing Marketplace, which offers competitive bids on sequencing projects from our global network of service providers. Our online forms help guide you to create an accurate description of your sequencing project, ensuring that you receive ...See more See less
Biocompare (www.biocompare.com) is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here.
The presentational method for this activity will be Lecture followed by Q&A. This virtual event targets all oncologists and primary care clinicians and is open to all health care professionals and academia. This activity will encompass the following desirable physician attributes: Patient Care & Procedural Skills, Medical Knowledge, Professionalism, and Practice-Based Learning & Improvement.
Desired Outcomes - at the conclusion of the activity, participants should be able to:
1. Integrate the provided content into practive in ways that are consistent with acknowledged practive guidelines and that improve patient management and outcomes
2.Utilize technologies currently available for use in the clinic and the limitations of these technologies
3.Apply current and established medical science principles and the application of these principles to patient care
4.Practice continuous self-assessment and learning to improve one’s professional and clinical practices, including how to interpret results in ways most useful to the patient
5.Cite the role of precision medicine in cancer research & oncology
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical Quality/California Medical Association (IMQ/CMA) through the joint providership of CME Consultants and LabRoots. CME Consultants is accredited by the IMQ/CMA to provide continuing medical education for physicians.
CME Consultants designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To download the Program Committee brochure here.
Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...See more See less
Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...See more See less
Dr. Antonio T. Baines is an Associate Professor in the Department of Biology at North Carolina Central University (NCCU) and an adjunct professor in the Department of Pharmacology in the School of Medicine at the University of North Carolina (UNC) Chapel Hill. He earned a ...See more See less
Dr. Blonder leads the Clinical Proteomics Group at the CRTP/FNL. FNL is a Federally Funded Research and Development Center operated by Leidos Biomedical Research, Inc., for the National Cancer Institute (NCI). In 1978, Dr. Blonder received his M.D. at the Rijeka University ...See more See less
Dr. Rajan T. Gupta, MD, is an Assistant Professor of Radiology in the Division of Abdominal Imaging at Duke University Medical Center, as well as the Director of the Abdominal Imaging Fellowship Program and a Faculty physician in the Duke Cancer Institute. Since 2009, he has been ...See more See less
Eric A. Klein, MD, is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic. His clinical interests are cancers of the prostate, testis and kidney. For several years, including the current edition, Dr ...See more See less
Fred Russell Kramer is Professor of Microbiology and Molecular Genetics at the New Jersey Medical School, and has been a Principal Investigator at the Public Health Research Institute for the past 25 years. He graduated from the University of Michigan in 1964 and received his ...See more See less
The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...See more See less
Successful Senior Scientific Business Executive with demonstrated expertise growing markets, revenues, product pipelines and expanding technical organizations into new business opportunities. Educational and business management experience in global markets, with quantified ...See more See less
Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...See more See less
Thomas J. Polascik, M.D. is Professor in the Duke Cancer Institute, the Department of Surgery at the Duke University Medical Center, Durham, NC. Dr. Polascik trained at the Brady Urological Institute, the Johns Hopkins Hospital in Baltimore Maryland. After finishing his residency ...See more See less
For bugs, spam, technical support or questions please call +1-714-463-4673 or
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events